BCAS1 anticorps (AA 532-550)

N° du produit ABIN1732242

Cet anticorps anti-BCAS1 Polyclonal Lapin (ABIN1732242) détecte spécifiquement BCAS1 dans WB et IHC. L’anticorps est réactif avec des échantillons de Humain.

Aperçu rapide pour BCAS1 anticorps (AA 532-550) (ABIN1732242)

Antigène: BCAS1 (Breast Carcinoma Amplified Sequence 1 (BCAS1))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp BCAS1 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC)

Détail du produit anti-BCAS1 anticorps

Épitope: AA 532-550

Specificité: Reacts with human BCAS1.

Purification: Purified

Immunogène: Synthetic peptide corresponding to amino acids 532-550 of human BCAS1/NABC1.

Isotype: IgG

Information d'application

Indications d'application: Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only:
WB(1 - 5 μg/mL)

Restrictions: For Research Use only

Stockage

Buffer: PBS, pH 7.4

Conseil sur la manipulation: Dilute in PBS or medium that is identical to that used in the assay system.

Stock: -20 °C

Stockage commentaire: Stable for at least one year at -20°C. Avoid multiple freeze-thaw cycles.

Date de péremption: 12 months

Détails sur BCAS1

Antigène: BCAS1 (Breast Carcinoma Amplified Sequence 1 (BCAS1))

Autre désignation: BCAS1 / NABC1

Sujet: Breast Carcinoma Amplified Sequence 1 (BCAS1), also known as Novel Amplified in Breast Cancer 1 (NABC1) was isolated from a region at 20q13 and is amplified in several tumor types. It is associated with more aggressive tumor phenotypes. BCAS1/NABC1 is highly expressed in some, but not all, breast cancer cell lines and in some breast tumors at 20q13.2. The BCAS1/NABC1 gene is predicted to encode a protein of 584 amino acids with no significant homology to other proteins.

Breast carcinoma-amplified sequence 1 Amplified and overexpressed in breast cancer Novel amplified in breast cancer 1 Gene name: BCAS1, AIBC1, NABC1

ID gène: 8537

UniProt: O75363